ライフサイエンスコーパス: medicine

1 boosted interest in the concept of 'food as medicine'.

2 , make it a promising resource for precision medicine.

3 oyed to treat infections in animal and human medicine.

4 dinal manner is a path forward for precision medicine.

5 ially in tissue engineering and regenerative medicine.

6 with different applications in personalized medicine.

7 ural alkaloid that is used as an antitussive medicine.

8 c advancement in the field of Chinese herbal medicine.

9 may also be used in studies for personalized medicine.

10 emphasis on their potential for personalized medicine.

11 ments in tissue engineering and regenerative medicine.

12 iscovery, disease modeling, and personalized medicine.

13 ce will be a valuable resource for precision medicine.

14 velopment of HFpEF therapy in cardiovascular medicine.

15 o target senescent cells in future geriatric medicine.

16 r clinical relevance in the era of precision medicine.

17 practices of pediatric radiology and nuclear medicine.

18 disease-modifying medicines in neurological medicine.

19 g processes for applications in regenerative medicine.

20 e directed in this evolving era of precision medicine.

21 pecialties, including pediatrics and nuclear medicine.

22 cardiomyocytes for research and regenerative medicine.

23 re therapeutic target in personalized cancer medicine.

24 e, and Mayo Clinic Center for Individualized Medicine.

25 instrumental in the realization of precision medicine.

26 emporal manner for personalized regenerative medicine.

27 , toxicology, cell therapy, and regenerative medicine.

28 onal spectroscopy in chemistry, biology, and medicine.

29 d improves biomarker discovery for precision medicine.

30 ecision medicine in the future in veterinary medicine.

31 t tool for risk stratification and precision medicine.

32 ild the best evidence base in cardiovascular medicine.

33 in saliva have significant value in clinical medicine.

34 epresents an exciting advance in respiratory medicine.

35 as become a major source of communication in medicine.

36 licable across various fields of biology and medicine.

37 learning in hepatology and liver transplant medicine.

38 51%) of vet drugs are also approved in human medicine.

39 graft versus host disease, and regenerative medicine.

40 apeutics have the potential to revolutionize medicine.

41 ches in the implementation of individualized medicine.

42 nteractions and disease mutations in genomic medicine.

43 use of biomaterial implant failure in modern medicine.

44 cepted for publication in Annals of Internal Medicine.

45 uations may transform the future practice of medicine.

46 ucleases is revolutionizing life science and medicine.

47 , highlighting the prospective for precision medicine.

48 model is an essential step toward precision medicine.

49 field of tissue engineering and regenerative medicine.

50 cture and predictive aspects of personalized medicine.

51 eded their use in translational regenerative medicine.

52 may have transformative effects on geriatric medicine.

53 tructing interpretable models for predictive medicine.

54 paving the way for precision cardiovascular medicine.

55 biology, developmental biology and precision medicine.

56 ent within our own Division of Critical Care Medicine.

57 porated into the design process for a living medicine.

58 h has important implications in regenerative medicine.

59 esponsible use of artificial intelligence in medicine.

60 cations as we move towards more personalized medicine.

61 ed Hospital of Zhejiang University School of Medicine.

62 tools for drug development and personalized medicine.

63 en approved by the FDA for use in veterinary medicine.

64 broad reaching implications for regenerative medicine.

65 is the typical therapeutic goal in clinical medicine.

66 tures with the potential to inform precision medicine.

67 ains a major burden for modern resuscitation medicine.

68 ), and (d) the potential future of precision medicine.

69 ns with liquid biopsies to deliver precision medicine.

70 tilize the discovery of molQTLs in precision medicine.

71 se (GVHD), providing a roadmap for precision medicine.

72 alized manner, entering the era of precision medicine.

73 n composites are widely used in industry and medicine.

74 actice Evaluation processes in critical care medicine.

75 ty that can exceed that for protein-targeted medicines.

76 ges for enabling sense-and-respond precision medicines.

77 ct on the affordability and accessibility of medicines.

78 processes for discovering and developing new medicines.

79 AAA itself as a target for anti-inflammatory medicines.

80 of drug substances in the development of new medicines.

81 bolism, Valvular Heart Disease, and Vascular Medicine (1-100).

82 as obtained from a guidebook "Evidence-Based Medicine 2018 SCL " which was published by Seoul Clinica

83 s for oncology were approved by the European Medicines Agency (EMA), 16 by the US Food and Drug Admin

84 ly treatment approved by either the European Medicines Agency or the U.S. Food and Drug Administratio

85 five key principles relevant to the European Medicines Agency, European medical device regulatory age

86 t-to-treat (ITT) population and the European Medicines Agency-defined primary endpoint was investigat

87 n the synthesis of molecules broadly used in medicine, agriculture and materials.

88 biology has revolutionized our approaches to medicine, agriculture, and energy, the design of complet

89 l products, they have been widely applied in medicine, agriculture, cosmetic and food industries.

90 ovides a practical way to approach precision medicine, allowing for more directed and efficient manag

91 s) continue to lack drug approval in Western medicine, an increasing number of patients are being tre

92 oles, the frontline antifungal class used in medicine and agriculture to control A. fumigatus, is com

93 Collaboration between emergency medicine and allergy departments may be helpful for impr

94 applications such as regenerative repair in medicine and biosensing in bioengineering.

95 obial ecosystems with potential benefits for medicine and biotechnology.

96 Rapid advancements in medicine and changing standards in medical education req

97 th the principles of the National Academy of Medicine and Council of Medical Specialty Societies.

98 Medicine and dentistry need to treat the individual not

99 s of many biomaterials used for regenerative medicine and drug delivery.

100 in schools of natural science, pharmacy, and medicine and have worked in multiple basic science depar

101 Atlas Ontology and the Ontology of Precision Medicine and Investigation - will support the creation o

102 ential to accelerate innovation in precision medicine and its delivery to individual patients.

103 overy of RNAi was awarded the Nobel Prize in Medicine and its success has accumulated since.

104 can College of Radiology, Society of Nuclear Medicine and Molecular Imaging, American Urological Asso

105 ce will require cooperation between nursing, medicine and policy makers.

106 rom the second Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT2) study, a randomized

107 ry findings are produced in other domains of medicine and public health, such as newborn screening pr

108 tudy was conducted in the Department of Oral Medicine and Radiology of the Dental Institute after obt

109 thopaedic, neurology, neurosurgery, physical medicine and rehabilitation clinics were evaluated.

110 among latent classes, skin-related, physical medicine and rehabilitation procedures as well as behavi

111 neurysm and dissection), integrated physical medicine and rehabilitation.

112 recommended by the Society of Critical Care Medicine and the Leapfrog Consortium.

113 ckson Foundation for Advancement of Military Medicine and the US Department of Defense, Ragon Institu

114 demonstrate the universal characteristics of medicine and the value of teamwork, flexibility and coll

115 SC may provide important clues for precision medicine and tumor-targeted therapy.

116 the late-stage trifluoromethylthiolation of medicines and agrochemicals.

117 -N coupling protocol by preparing commercial medicines and by the late-stage amination-aromatization

118 ed polymerization, setting the stage for new medicines and materials.

119 6 years in the United States (Yale School of Medicine), and 16 years in Switzerland (ETH Zurich).

120 many fields including developmental biology, medicine, and agriculture.

121 ity as a functional ingredient in food, folk medicine, and animal nutritions, as well as in nanotechn

122 Despite its ubiquitous use in medicine, and extensive knowledge of its molecular and c

123 expand their applications in biotechnology, medicine, and research.

124 great potential to impact science, industry, medicine, and society, and recent improvements in DNA sy

125 as been regarded as a reactive species-based medicine, and the physical factors in CAP such as the th

126 or quantitative representation and precision medicine, and thus, automatic ranking to figure out the

127 itro and in vivo models, to enable precision medicine application of NOTCH-directed therapy in CCA as

128 A precision medicine approach based on treatment response would aim

129 f these confounders, we take an experimental medicine approach to examine the in vivo utility of remd

130 lent of biomarkers to help bring a precision medicine approach to RPT implementation when merited by

131 has prompted attempts to develop a precision medicine approach, with research aimed towards stratifyi

132 with psoriatic arthritis, so that stratified medicine approaches can be taken; another is predicting

133 The development of precision medicine approaches for diffuse large B cell lymphoma (D

134 r biomarkers in the development of precision medicine approaches for this severe mental disorder.

135 of mental disorders by developing precision medicine approaches globally.

136 ate the advent of microbiome-based precision medicine approaches in inflammatory arthritis, including

137 e incorporation of big data and experimental medicine approaches should aim to reduce the failure rat

138 Regenerative medicine approaches to enhancing beta cell growth and su

139 elevant to the current emphasis on precision medicine approaches to the blockade of pathways involved

140 ction and could inspire innovative precision medicine approaches.

141 r disparities in implementation of precision medicine are complex, due in part to differences in clin

142 Articles on Wikipedia about health and medicine are maintained by WikiProject Medicine (WPM), a

143 models, tissue engineering, and regenerative medicine are provided to further motivate future opportu

144 atment strategy by implementing personalized medicine are warranted to achieve optimal disease contro

145 in is challenging and novel non-opioid-based medicines are needed.

146 shows excellent prospects for application in medicine as next-generation biomaterials.

147 re screening via the U.S National Library of Medicine bibliographic database (MEDLINE) and Embase, 29

148 7 European-ancestry participants of the Penn Medicine Biobank (median age at enrollment 63 years, int

149 izes selected applications in areas, such as medicine, biology, oceanography, bioprocess monitoring,

150 erest in many different disciplines, such as medicine, biotechnology, physics and biocomputing.

151 ntial attention for its many applications in medicine, both as a catalyst for research and as a means

152 igence (AI) holds promise for cardiovascular medicine but is limited by a lack of large, heterogeneou

153 the USA alone and is listed as an essential medicine by the World Health Organisation.

154 ar disorders and are classified as essential medicines by the World Health Organization(1,2).

155 sing the FoundationOne CDx assay (Foundation Medicine, Cambridge, MA, USA).

156 merging therapies for PsD, so that precision medicine can be applied to rapidly improve clinical outc

157 comes suggest that the adoption of precision medicine can have a substantial effect on survival in pa

158 High-resolution approaches from molecular medicine can provide unparalleled insight into organisma

159 With the growing emphasis on personalized medicine, cell therapies hold great potential for their

160 To achieve the mission of personalized medicine, centering on delivering the right drug to the

161 e Cancer Foundation, the Experimental Cancer Medicine Centres Network, and the National Institute for

162 tes, single active enantiomer or achiral) of medicines circulated on the market particularly in Afric

163 ntified through Systematized Nomenclature of Medicine codes from the ESPRESSO (Epidemiology Strengthe

164 a and the Society for Imaging Informatics in Medicine conferences (November 2016-June 2019), then nar

165 A recent study in Nature Medicine contributes to growing evidence that genomic as

166 ial oil has multiple benefits in traditional medicine, cosmetics, and food industries.

167 o evaluate the impact of COVID-19 on nuclear medicine departments.

168 alth expenditures include paying for general medicine, diagnostic procedures, hospitalizations and su

169 blished: the European Association of Nuclear Medicine (EANM) criteria, the Prostate Cancer Molecular

170 in Nature Medicine elucidates several mechanisms to inhibit the ex

171 omising future in biomedical engineering and medicine, especially as an alternative to current synthe

172 esource for the advancement of the precision medicine field.

173 ties, paving the way toward making precision medicine for AMD patients a reality in the near future.

174 Robust developments of personalized medicine for next-generation healthcare highlight the ne

175 ely used throughout the world as traditional medicine for treating a variety of diseases ranging from

176 sophageal disorders and the non-prescription medicines for acid reflux.

177 ders, and to the development of personalized medicines for them.

178 itating rational repurposing of the existing medicines for treating COVID-19.

179 dex of all 108 070 Trans-Omics for Precision Medicine Freeze 5 chromosome 17 haplotypes.

180 materials science, nanotechnology, biology, medicine, geology, optics, catalysis, art conservation a

181 lar imaging and radioguided surgery, nuclear medicine has been instrumental in the realization of pre

182 Therefore, plasma medicine has been regarded as a reactive species-based m

183 field of tissue engineering and regenerative medicine has made numerous advances in recent years in t

184 importance of complex traits in biology and medicine has motivated diverse approaches to understandi

185 Calls for adherence to evidence-based medicine have emerged during the initial wave of the COV

186 r Genome Atlas and Trans-Omics for Precision Medicine) have the potential to revolutionize systems bi

187 fessional Practice Evaluation, critical care medicine, healthcare quality, and The Joint Commission.

188 h Organization publishes a list of essential medicines, i.e., those that satisfy the priority health

189 onal Association for Intelligent Biology and Medicine (IAIBM) is a nonprofit organization that promot

190 ell as Digital Imaging and Communications in Medicine image data of knee images for accelerated MR im

191 F intraventricular space followed by nuclear medicine imaging at 90 min, 4 h, 24 h, and 48 h (if requ

192 and confirmed by ultrasound, CT, or nuclear medicine imaging.

193 t overcome critical barriers in conventional medicine in a unique manner, but also to deliver within

194 most important emerging aspects of precision medicine in cancer is matching patients and treatments b

195 acterization of tumors and promote precision medicine in cancers.

196 ical significance, management, and precision medicine in diabetes clinics.

197 s could provide a framework for personalized medicine in diabetes.

198 la sativa), is considered a traditional folk medicine in Saudi Arabia where it is widely available in

199 e cohort analysis might facilitate precision medicine in the future in veterinary medicine.

200 eatment responses thus enabling personalized medicine in the selection of specific treatment regimens

201 -resource settings, thereby bringing genomic medicine in these countries closer to clinical fruition.

202 aneous testing of multiple disease-modifying medicines in neurological medicine.

203 fundamental determinants of use of biologic medicines in sub-Saharan Africa.

204 tablished the chirality status of registered medicines in Tanzania by conducting a retrospective cros

205 coumarin derived from a traditional Chinese medicine, in preclinical models of asthma.

206 sh these "living therapies" from traditional medicines, including their ability to expand and contrac

207 Studentship in Vaccine Research, Innovative Medicines Initiative 2 Joint Undertaking, EBOVAC (grant

208 cs and therapeutics has introduced precision medicine into a widened field of complement-mediated dis

209 the potential to fundamentally alter the way medicine is practised.

210 tanding of lipid peroxidation in biology and medicine is rapidly evolving, as it is increasingly impl

211 An important aspect of precision medicine is to probe the stability in molecular profiles

212 A goal in precision medicine is to use patient-derived material to predict d

213 ems, a rapidly growing subfield of precision medicine, is presented.

214 at 31 respiratory, sleep, and critical care medicine journals to consolidate contemporary best pract

215 The promise of precision medicine lies in data diversity.

216 The future of the American Board of Internal Medicine Maintenance of Certification (MOC) program is a

217 The National Library of Medicine (MEDLINE/PubMed) was systematically searched fr

218 Forty-eight medicine-naive MDD patients plus 33 healthy controls (HC

219 ting programmable nucleic acid components in medicine, nanotechnology, and biocomputing.

220 optimal diagnosis, prognosis, and precision medicine, no single ruling technology exists.

221 These novel medicines not only bring significant benefit to patients

222 al care medicine, palliative care, pediatric medicine, nursing, social work, gerontology, geriatrics,

223 the Department of Experimental and Clinical Medicine of University of Florence (the ex-60% fund and

224 pproved more quickly than de novo discovered medicines on new targets.

225 ith lung cancer, the discovery of stratified medicine options for tobacco-associated NSCLC is a high

226 nt studies in brain science and neurological medicine paid a particular attention to develop machine

227 rse working group representing critical care medicine, palliative care, pediatric medicine, nursing,

228 In Science Translational Medicine, Park et al. develop an oncolytic vaccinia viru

229 manual readings in a subcohort (by 1 nuclear medicine physician).

230 T scans (n = 204) were reviewed by 1 nuclear medicine physician.

231 ed images were blindly reviewed by 3 nuclear medicine physicians and scored (using a Likert scale of

232 lysis was performed by 3 independent nuclear medicine physicians applying the molecular imaging TNM s

233 All scans were interpreted by 4 nuclear medicine physicians.

234 2 editors of journals in ecology, economics, medicine, physics and psychology.

235 New York Presbyterian Hospital-Weill Cornell Medicine PICU physician group continued to lead this uni

236 and applications of REA across the precision medicine pipeline may contribute to inconsistencies in d

237 prerequisite for harnessing the regenerative-medicine potential of these cells in the clinic.

238 Currently, multiple medicines prescribed to large numbers of patients influe

239 ion: Both diagnostic and therapeutic nuclear medicine procedures declined precipitously, with countri

240 k assessment could be utilized for precision medicine purposes.

241 loited to devise strategies for regenerative medicine purposes.

242 ntly published in the New England Journal of Medicine report on an oral lutenizing-hormone-releasing

243 Precision medicine requires accurate technologies for drug adminis

244 ormance with European Association of Nuclear Medicine Research Ltd.

245 ely involved in the Society of Critical Care Medicine's ICU Liberation Campaign, reviewed the pertine

246 akeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guid

247 The nascent field of bioelectronic medicine seeks to decode and modulate peripheral nervous

248 ving forward, the American Board of Internal Medicine should cocreate MOC with the physician communit

249 The future of precision medicine should therefore involve tailoring of therapy b

250 Two recent papers published in Nature Medicine showcase the successful application of cfDNA me

251 applicative exploration of nanocarrier-based medicines showing significant potential, but in particul

252 nt, this approach may provide a regenerative medicine solution to uterine factor infertility.

253 edicted PET images was assessed by 2 nuclear medicine specialists using a 5-point grading scheme.

254 The Society of Critical Care Medicine standard operating procedures manual and confli

255 mmendation, as suggested by the Institute of Medicine Standards for Trustworthy Guidelines.

256 he fight for social justice and diversity in medicine stems from racial inequalities and discriminati

257 nous matrix and suggesting that regenerative medicine strategies should change focus from the fibrous

258 in IR in further development of personalized medicine strategies to effectively treat MDD.

259 Nuclear medicine studies are often performed in patients with br

260 ouble-blind, placebo-controlled experimental medicine study, healthy adults were randomized to an FAA

261 The use of nuclear medicine techniques can add crucial complementary inform

262 ited from the broad application of precision medicine techniques to hematolymphoid neoplasms.

263 results should also aid the applications in medicine that are now entering the clinic.

264 tion and development of carbohydrate-derived medicines that bring the field to the next level of scie

265 Regenerative medicines that promote remyelination in multiple scleros

266 of Pediatrics, the Society of Critical Care Medicine, the American Medical Association, and the Asso

267 tial for metabolic phenotyping in stratified medicine, this study reveals an important role for activ

268 de are combining their knowledge of biology, medicine, tissue engineering, and microtechnology to dev

269 and under-recognized role of engineering in medicine to address the multitude of challenges in cance

270 d functional imaging in delivering precision medicine to children with neuroblastoma.

271 scientists, with expertise from evolutionary medicine to cultural evolution, provide insights about t

272 role in chemical biology, pharmacology, and medicine to discover safe and efficacious drugs.

273 to a variety of domains from engineering and medicine to economics and social planning.

274 The introduction of precision medicine to manage this chronic, complex condition is a

275 reduce the costs and risks of bringing a new medicine to market.

276 provides a clinical venue to allow molecular medicine to rapidly advance, answers questions that trad

277 ed medication doses to save money; took less medicine to save money; delayed filling a prescription t

278 Such studies are required to bring precision medicine to the bedside of critically ill patients with

279 udies in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program.

280 nd Blood Institute Trans-omics for Precision Medicine (TOPMed) programme, and identify 4,229 individu

281 urn assessment in settings such as emergency medicine triage and low resource environments.

282 n and, if so, whether this affects precision medicine trial design.

283 the intervention (30% in the MICU and 50% in medicine units).

284 h has been underrecognized in cardiovascular medicine until recently.

285 ned an unfulfilled promise in cardiovascular medicine until today.

286 urgeries, prescriptions and over-the-counter medicine use, and impaired health-related quality of lif

287 In agriculture and medicine, using mixtures of compounds from different cla

288 In the New England Journal of Medicine, Wang et al. report favorable ZUMA-2 trial resu

289 D-19 pandemic occurred more often on general medicine wards than in intensive care units (46% versus

290 blic after the Nobel Prize for Physiology or Medicine was awarded in 2016 to Yoshinori Ohsumi for dis

291 In the overall scenario of precision medicine, we propose a novel paper-based lab-on-a-chip t

292 data analysis necessary for kidney precision medicine, where heterogeneous clinical, imaging and biop

293 m and enable the implementation of precision medicine, whereby patient management is tailored to the

294 ssary and fundamental step towards precision medicine, which will benefit men's and women's health.

295 These improvements in precision medicine will be achieved, in part, by employing novel m

296 Continued progress in this field of medicine will require (1) improvements in our understand

297 romises a future of rigorous, outcomes-based medicine with detection, diagnosis, and treatment strate

298 Medicines with a stereogenic center (asymmetric carbon)

299 pleiotropy for applications in evolutionary medicine would benefit from focusing on traits with corr

300 h and medicine are maintained by WikiProject Medicine (WPM), and are widely used by health profession